▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #658 by analyst upside · 2026-11-13
STTK
Shattuck Labs, Inc.
Healthcare · Market Cap $490M · P/E 0x
ANALYST PRICE TARGET
+220.2%
implied upside to consensus target
Current Price $4.81
Consensus Target $15.4
Bull Target $19.0
Bear Target $10.0
Analysts Covering 10
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
8
Hold
0
Sell
0
52-Week Low $1.72
52-Week High $8.33
YTD Return +29.6%
FUNDAMENTALS
Market Cap $490M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.47
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $1.72
52-Week High $8.33
Current Price $4.81
Bear Target $10.0
Bull Target $19.0
● Now $4.81 ● Target $15.4
TRADING DATA
Avg Volume 1.1M
YTD Return +29.6%
Analyst Count 10
Consensus Buy
Upside to Target +220.2%
Last Updated 2026-11-13

ANALYST SUMMARY

Shattuck Labs, Inc. (STTK) is currently trading at $4.81 with a Wall Street consensus price target of $15.4, implying potential upside of 220.2% over the next 12 months. 10 analysts currently cover STTK, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $19.0, while the most cautious has a target of $10.0.

STTK operates in the Healthcare sector with a market capitalisation of $490M. The stock is up 29.6% year-to-date and is currently trading near the lower end of its 52-week range of $1.72 – $8.33.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for STTK, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS ● Initiated
Buy 2026-10-12 33% win rate (6 calls)
Wedbush - Reiterated
Outperform → Outperform 2026-10-02 Building track record
Needham - Reiterated
Buy → Buy 2026-10-02 20% win rate (5 calls)
Raymond James ● Initiated
Strong Buy 2026-08-24 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-08-11 31% win rate (48 calls)
JP Morgan ● Initiated
Overweight 2026-07-24 43% win rate (7 calls)
Leerink Partners ● Initiated
Outperform 2026-07-20 29% win rate (7 calls)
Citigroup - Reiterated
Buy → Buy 2026-06-09 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
45
out of 100
Coverage depth
18/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →